Florian Schodel, MD, Ph.D.
Dr. Schodel serves a key consultant for our vaccine Clinical Development Plans, drawing upon his extensive experience at Merck, where he served as the VP of Clinical Research and the Executive Director of Biologics / Vaccines Clinical Research. He also possesses a strong record in clinical development consulting and has provided services to GSK, the Wellcome Trust, Gates Foundation, PATH, and various other institutions.
Gerard Cunningham, MBA
Gerard Cunningham operates as our business strategy and new product development director through his capacity at Integrated Global Health. He possesses extensive business development and strategy experience at Merck, where he served as the Executive Director of Strategic Planning in Emerging Markets and the Director of New Vaccine Marketing. Furthermore, he has additional experience working in and interfacing with philanthropic funding bodies. Most notably, he served as a Senior Program Officer in Vaccine Delivery for the Gates Foundation.
Hugues Bogaerts, MD
HB Consulting provides advice and training on medical affairs, clinical development and various matters related to biopharmaceuticals with a focus on vaccines and external expert interactions. Dr. Bogaerts draws upon on more than 30 years of experience in various managerial capacities at the global level with major vaccine and/or pharmaceutical companies.
Pieter Neels, MD
Dr. Neels works as an independent consultant and specializes in developing regulatory pathways for vaccine and therapeutic indications. Dr. Neels is a member of the Committee for Medicinal Products for Human Use (CHMP).
John Hennessey, Ph.D.
Dr. Hennessey works as an independent consultant specializing in developing strategies for technical planning, preclinical & early clinical development, and manufacturing scale-up of vaccine candidates. Dr. Hennessey also has extensive experience with development needs for both developed and developing world commercial products.
David Robinson, Ph.D.
Dr. Robinson provides guidance and strategic oversight on all phases of CMC product development from initial development to product launch. Dr. Robinson's background provides a unique perspective at the intersection of process development, product commercialization and CMC regulatory for Vaccines and Biologics
Danforth provides modular financial and accounting services.
Wilmer Cutler Pickering Hale and Dorr LLP
Wilmerhale provides legal services.
Hodgson Russ LLP
Hodgson provides legal services.